Anika Therapeutics, Inc. Accrued Income Taxes, Current
Anika Therapeutics, Inc. (ANIK) had Accrued Income Taxes, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-03-03
- 2025-12-31: Accrued Income Taxes, Current $0.00.
- 2025-09-30: Accrued Income Taxes, Current $0.00.
- 2025-06-30: Accrued Income Taxes, Current $0.00.
- 2025-03-31: Accrued Income Taxes, Current $65.00K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-03 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-30 |
| 2025-03-31 | $65.00K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $63.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $82.00K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $77.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.24M 10-K · filed 2025-03-17 |
| 2023-09-30 | $819.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $931.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $889.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $810.00K 10-K · filed 2024-03-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2019-09-30 | $766.00K 10-Q · filed 2019-10-28 |
| 2019-06-30 | $757.00K 10-Q · filed 2019-07-26 |
| 2019-03-31 | $1.30M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $385.00K 10-K · filed 2020-03-06 |
| 2017-06-30 | $2.30M 10-Q · filed 2017-07-28 |
| 2016-12-31 | $0.00 10-Q · filed 2017-07-28 |
| 2016-09-30 | $217.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $591.00K 10-Q · filed 2016-08-01 |
| 2016-03-31 | $1.60M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $4.20M 10-K · filed 2017-02-24 |
| 2015-09-30 | $4.44M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $1.82M 10-Q · filed 2015-08-04 |
| 2014-06-30 | $232.70K 10-Q · filed 2014-08-04 |
| 2014-03-31 | $424.99K 10-Q · filed 2014-05-05 |
| 2013-12-31 | $770.28K 10-K · filed 2015-03-13 |
| 2013-09-30 | $542.30K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $1.37M 10-Q · filed 2013-08-06 |
| 2012-12-31 | $1.80M 10-K · filed 2014-03-13 |
| 2012-09-30 | $1.39M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $2.53M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $235.33K 10-Q · filed 2012-05-07 |
| 2011-12-31 | $450.48K 10-K · filed 2013-03-14 |
| 2011-09-30 | $1.32M 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |